lincomycin has been shown to be active in vitro against the following microorganisms: aerobic gram-positive cocci: streptococcus pyogenes and viridans group streptococci; aerobic gram-positive bacilli: corynebacterium diphtheriae; anaerobic gram-positive non-sporeforming bacilli: propionibacterium acnes; anaerobic gram-positive sporeforming bacilli: clostridium tetani and clostridium perfringens. lincomycin inhibits protein synthesis in susceptible bacteria by binding to the 50 s subunits of bacterial ribosomes and preventing peptide bond formation upon transcription.
Parent Term
Biochemical pathway
Parent Definition
A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.
Other Metabolites Mapped to 'Lincomycin Action Pathway'